Difference between revisions of "Insulin-like growth factor-binding protein-1"
m |
|||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Revision as of 13:55, 7 January 2008
| Template:Infobox header| Insulin-like growth factor-binding protein-1 | |
|---|---|
| Substrate peptide name | Insulin-like growth factor-binding protein-1 |
| Synonyms | IGFBP-1 |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular fluids |
| Swissprot ID | P08833 |
| Reactive glutamines | Q66, Q67 |
| Reactive lysines | Not determined yet |
| Substrate sequence | ALPGEQQPLHAL |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:11121406 |
| Notes | Upon transglutaminase action IGFBP-1 forms multimers and this cause the loss of binding affinity to IGF-1 |
| Template:Infobox header | |
